Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Geron Corp (GERN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 329,939
  • Shares Outstanding, K 186,406
  • Annual Sales, $ 1,070 K
  • Annual Income, $ -27,020 K
  • 60-Month Beta 2.95
  • Price/Sales 304.26
  • Price/Cash Flow N/A
  • Price/Book 1.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.58 +12.03%
on 03/28/19
2.14 -17.29%
on 04/11/19
+0.13 (+7.93%)
since 03/18/19
3-Month
0.99 +78.79%
on 01/23/19
2.14 -17.29%
on 04/11/19
+0.68 (+62.39%)
since 01/18/19
52-Week
0.95 +85.34%
on 12/21/18
6.99 -74.68%
on 09/13/18
-1.97 (-52.67%)
since 04/18/18

Most Recent Stories

More News
Geron Expands Senior Leadership of Its Development Team

Geron Corporation (Nasdaq: GERN) today announced an expansion of its development team's senior leadership with the addition of three highly experienced professionals for key functional areas. Their oncology...

GERN : 1.77 (+1.72%)
Healthcare Companies Search for New Ways to Oppose the Spread of Cancer

Cancer is among one of the leading causes of death in the world since many countries are burdened by the lack of access to adequate healthcare, which results in the high number of deaths. In 2018, the...

CRIS : 1.77 (-2.75%)
CVM : 5.95 (+2.94%)
GERN : 1.77 (+1.72%)
SNETD : 0.3900 (+14.71%)
SNET : 0.0240 (unch)
NLNK : 1.59 (+1.27%)
Why International Regulations on Clinical Trials can Actually Reduce Costs and Shorten Time to Market

Every business or industry strives to improve quality, reduce costs and improve their products time to market. This, surprisingly, is true for the biotechnology industry as well. Usually regulations increase...

TEVA : 14.36 (+0.98%)
OPK : 2.40 (-0.41%)
GERN : 1.77 (+1.72%)
GILD : 62.95 (-0.47%)
MBRX : 1.11 (+14.08%)
Latest Biotechnology Advancements may be Key to Unlock new Autism Treatments

According to the Centers for Disease Control, autism affects an estimated 1 in 59 children in the United States today. The Autism Speaks website defines the main problem for researchers/practitioners...

QBIO : 1.8300 (-1.08%)
GERN : 1.77 (+1.72%)
INSM : 29.84 (+1.29%)
PHAS : 12.82 (-9.08%)
CMRX : 2.62 (+0.38%)
Why Is Geron (GERN) Up 27.3% Since Last Earnings Report?

Geron (GERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GERN : 1.77 (+1.72%)
New Research: Key Drivers of Growth for Geron, Hess, Royal Gold, Lear, Menlo Therapeutics, and CorEnergy Infrastructure Trust -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Geron Corporation (NASDAQ:GERN),...

MNLO : 7.33 (+0.69%)
CORR : 37.51 (-0.24%)
HES : 65.86 (-0.09%)
LEA : 157.83 (+0.23%)
GERN : 1.77 (+1.72%)
RGLD : 89.71 (-0.63%)
Geron to Present at Needham Healthcare Conference

Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, is scheduled to present a company overview at the 18th Annual Needham Healthcare Conference...

GERN : 1.77 (+1.72%)
Geron Appoints Two New Independent Board Members

Geron Corporation (Nasdaq: GERN) today announced the appointments of Dawn C. Bir and Elizabeth G. O'Farrell as independent members of its Board of Directors. In addition, Ms. Bir will serve as a member...

GERN : 1.77 (+1.72%)
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 78,400 shares of Geron common stock as inducements to two newly-hired employees...

GERN : 1.77 (+1.72%)
Do Options Traders Know Something About Geron (GERN) Stock We Don't?

Investors need to pay close attention to Geron (GERN) stock based on the movements in the options market lately.

GERN : 1.77 (+1.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More Share

Trade GERN with:

Business Summary

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking...

See More

Key Turning Points

2nd Resistance Point 1.85
1st Resistance Point 1.81
Last Price 1.77
1st Support Level 1.72
2nd Support Level 1.67

See More

52-Week High 6.99
Fibonacci 61.8% 4.68
Fibonacci 50% 3.97
Fibonacci 38.2% 3.26
Last Price 1.77
52-Week Low 0.95

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar